According to the Data Safety and Monitoring Board, the trials were supposed to commence from the first week of September but now awaits approval for the security of the starting 100 participants recruited until now. Oxford Astrazeneca has produced one of the most anticipated vaccine named covishield in India. Covishield is one of the three vaccines which is under trials. Covishield is one of the three vaccines which is under trials such as Zydus Candila’s ZCOV-D and Bharat Biotech’s Covaxin.
However, reports suggest, that the trials of Oxford Covishield may take place later this week. Due to it, the recruitment of the volunteers has been thrown on the hold.
Oxford Vaccine trial delayed
At the PGIMER, the vaccine trial schedule, Dr. Madhu Gupta says “Currently, the recruitment for the trial of Oxford vaccine has been put on the halt, they have been waiting for the approval of safety of the initial 100 volunteers. In this matter, they will be able to update anything later this week”.
As per the premier institute, they have received around 400 people for trial. 253 out of them, would be given the first dose of pendent vaccine. Earlier, Dr Madhu Gupta informed, a team of 17 members including herself would be supervising the clinical trials. The vaccine trial will be looked at after the marketing and production of the Serum Institute of India (SII).
The chief executive officer of the Pune-based firm, Adar Poonawalla has given an indication on the arrival of the vaccine in India. He confirmed that the COVID-19 vaccine might be ready by the end of 2020. Stay connected with us to get the latest updates from India and around the world.COVID-19: Russian vaccine trial successful in human